Maximus Inc (MMS)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Maximus Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 9 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 60.30 $ — 14% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
5 of 10 Solid growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 5.5% failed
- More than 10% revenue growth is expected for the coming year 4.8% failed
- Share count grows by less than 3% a year -2.2% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 9.1% failed
- Gross margin at 40% or higher and without meaningful erosion 23.0% failed
- Goodwill from acquisitions does not grow faster than revenue 43.8% passed
- Net debt below twice EBITDA 1.8 x EBITDA passed
- Operating cash flow covers the profits of the last three years 471 m passed
- Return on capital at 15% or higher, or up versus two years ago 17.5% passed
- Insiders hold at least 10% or are net buyers 1.8% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 74.1% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 2
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 09/30/2026 | 8.44 | 8.36 – 8.47 | 5,296 | 14.6% | 2 |
| 09/30/2027 | 9.07 | 8.95 – 9.19 | 5,551 | 7.5% | 2 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 2.20 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.69 | -34.10 | 1,403 | 5.70 | 2.90 | -80 | -103 |
| 2025: Q1 | 1.69 | 29.50 | 1,362 | 1.00 | 7.10 | 43 | 26 |
| 2025: Q2 | 1.86 | 27.20 | 1,348 | 2.50 | 7.90 | -183 | -198 |
| 2025: Q3 | 1.32 | 12.00 | 1,318 | 0.20 | 5.70 | 649 | 642 |
| 2025: Q4 | 1.70 | 147.40 | 1,345 | -4.10 | 7.00 | -244 | -251 |
| 2026: Q1 | 1.79 | 5.50 | 1,306 | -4.10 | 7.50 | 190 | 179 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 2,403 | 283 | 178 | 2.69 | 180 | 749 | 1,349 |
| 2017 | 2,451 | 315 | 209 | 3.17 | 337 | 940 | 1,351 |
| 2018 | 2,392 | 300 | 221 | 3.35 | 324 | 1,086 | 1,462 |
| 2019 | 2,887 | 320 | 241 | 3.72 | 357 | 1,248 | 1,746 |
| 2020 | 3,462 | 291 | 215 | 3.39 | 245 | 1,242 | 2,025 |
| 2021 | 4,254 | 419 | 291 | 4.67 | 517 | 1,480 | 4,119 |
| 2022 | 4,631 | 312 | 204 | 3.29 | 290 | 1,549 | 3,993 |
| 2023 | 4,905 | 295 | 162 | 2.63 | 314 | 1,668 | 3,986 |
| 2024 | 5,306 | 492 | 307 | 4.99 | 515 | 1,843 | 4,132 |
| 2025 | 5,431 | 577 | 319 | 5.51 | 429 | 1,674 | 4,070 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Maximus, Inc. ist weltweit als Anbieter von Behördendienstleistungen tätig.
| CEO Insider Trades (12 Mo.) | buying own stock |
|---|---|
| Employees | 37,200 |
| Headquarters | McLean, VA |
| Address | 1600 Tysons Boulevard, 22102 McLean, United States |
| Phone | 703 251 8500 |
| Website | maximus.com |
| IPO Date | 12. Jun 1997 |
| ISIN | US5779331041 |
| Stock Split | 2:1 on 07/01/2013 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Bruce L. Caswell | President, CEO & Director | 1967 |
| David W. Mutryn CPA | CFO & Treasurer | 1983 |
| Michelle F. Link | Chief Human Resources Officer | 1975 |
| Ilene R. Baylinson | General Manager of Health Services U.S. | 1958 |
| Theresa D. Golinvaux | Principal Accounting Officer, Senior VP & Corporate Controller | 1975 |
| Mike Raker | Chief Technology Officer | – |
| Derrick Pledger | Chief Digital & Information Officer (CDIO) | – |
| Elizabeth Moellering | General Counsel & Corporate Secretary | – |
| Jericho Seguin | Chief Corporate Development Officer | – |
| Jason Tone | Senior VP of Technology & Consulting Services of Healthcare | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.